Immodulon Therapeutics' Unattributed Round

Immodulon Therapeutics raised a round of funding on June 01, 2015.

Immodulon is a biopharmaceutical company pioneering immunotherapy cancer treatments - an approach now recognized as the biggest breakthrough since chemotherapy.…

Articles about Immodulon Therapeutics' Unattributed Round: